2-134550582-T-C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 3P and 6B. PM1PP2BP4_ModerateBS2
The NM_030923.5(TMEM163):c.446A>G(p.His149Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,614,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030923.5 missense
Scores
Clinical Significance
Conservation
Publications
- leukodystrophy, hypomyelinating, 25Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152184Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000716 AC: 18AN: 251318 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461794Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727198 show subpopulations
GnomAD4 genome AF: 0.000243 AC: 37AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74458 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.446A>G (p.H149R) alteration is located in exon 4 (coding exon 4) of the TMEM163 gene. This alteration results from a A to G substitution at nucleotide position 446, causing the histidine (H) at amino acid position 149 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at